MedTrace Logo

Mild Depression 2 Week Observational Study

NCT00285831 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2019-09-09

No results posted yet for this study

Summary

The purpose of this study is to assess whether the dysphoric-like depressive characteristics observed in people with epilepsy are unique to this patient population in comparison to three control groups: Mild Depression (enrolled at Stanford University), Migraine Headaches (enrolled at Long Island Jewish Medical Center), and Multiple Sclerosis (enrolled at Rush University Medical Center).

Conditions

  • Depressive Disorder

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Long Island Jewish Medical Center

    collaborator OTHER

  • Rush University Medical Center

    collaborator OTHER

  • Stanford University

    lead OTHER

Principal Investigators

  • John J Barry · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00285831 on ClinicalTrials.gov